Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age

2023/11/30 by Yuka Uesugi, Daisuke Ikeda, Ami Fukumoto +5
Medicine · #Multiple Myeloma Research and Treatments

paper · pdf · doi:10.3324/haematol.2023.284173

openalex publication_date 2023/11/30 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

Not available.

Related

• International Staging System for Multiple Myeloma
• Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real‐world analysis from the Chinese Myeloma Committee
• Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
• Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
• The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial